ORA

Orora Limited

Materials • ASX • Updated May 24, 2026
Analyst Summary
Orora is an Australian beverage packaging manufacturer operating across glass and aluminium cans. We analyse its post-transformation business quality, financial trajectory, and key risks.

Thesis

Orora is a competent but not exceptional packaging manufacturer whose real asset, a domestic Cans duopoly, is being obscured by the market's punishment of its troubled Saverglass acquisition. The business earns a return on invested capital of roughly 8-9%, adequate but not outstanding. The Cans division operates in a structural duopoly with high barriers to entry and multi-year growth visibility. Saverglass introduces genuine earnings uncertainty that the market is pricing aggressively. The balance sheet, at 0.9 times net debt to EBITDA with $942 million of undrawn facilities, provides substantial cushion against prolonged weakness. The post-transformation portfolio has been operating together for less than two years, which limits confidence in any normalised earnings estimate.
Fair Value Estimate: ██████ Members only

The Business

Orora operates in three segments. Saverglass, acquired in mid-2024, manufactures premium glass bottles for spirits and wine producers across Europe and the Middle East, contributing roughly half of group revenue. The Australasian Beverage Cans division produces aluminium cans in a duopoly with Visy, one of only two manufacturers serving Australia. Gawler, a smaller glass operation in South Australia, rounds out the portfolio. The company sold its North American distribution business (OPS) in December 2024 for $1.1 billion, completing a transformation into a pure-play beverage packaging manufacturer. The current portfolio has been operating together for less than two years.

Recent Performance

Orora's share price has roughly halved from around $2.50 over the past 18 months. The catalyst was a series of downgrades to Saverglass earnings guidance, most recently driven by the Hormuz Strait closure disrupting production at its UAE facility and a global destocking cycle in premium spirits. FY25 group revenue of $2.09 billion included the first full year of Saverglass contribution. Group EBITDA reached $419 million, a 20% margin. But the market is focused on the trajectory, not the level.

Outlook

FY26 is a trough year. We forecast EBITDA of $385 million as Saverglass absorbs conflict-related costs and weaker spirits demand. The recovery path runs through FY27-FY28 as those headwinds fade: Saverglass order intake is already up 18% year-to-date, and Cans volumes grew 11% in the first half of FY26. The more significant shift is in capital expenditure: $200 million in FY26 drops to $110 million in FY27 as growth projects complete, transforming free cash flow from $123 million to $218 million on just 4.4% revenue growth. That capex cliff is the single most important number in this report.

Key Risks

Saverglass may never recover if spirits demand is structurally impaired by health trends and GLP-1 medications. The $766 million of goodwill from the acquisition sits with only 89 basis points of headroom before an impairment test fails, a non-cash but sentiment-damaging event. Prolonged Hormuz closure beyond 18 months would permanently shift production to higher-cost facilities, dragging earnings by €15-20 million annually.

What to Watch

The thesis-defining event is the FY26 full-year result in August 2026, which will confirm whether Saverglass EBIT lands within the guided €52-59 million range and whether order intake momentum has translated into revenue recovery.

  • Next 12 months Hormuz de-escalation signals — Resolution would remove a meaningful embedded discount and accelerate multiple re-rating.
  • Feb 2027 FY27 interim confirming Cans EBIT progress — Delivery against the $50m incremental EBIT target validates the duopoly growth thesis.
Reassess Valuation If
Saverglass order intake exceeds +5% YoY for two consecutive quarters, confirming cyclical recovery thesis.
Exit/Reduce If
Saverglass EBIT falls below €50m for a full year without Middle East disruption, or net debt/EBITDA exceeds 2.5x.

Business

Company Description

Orora is an Australian-listed beverage packaging manufacturer operating across three divisions. Saverglass, headquartered in France, is one of Europe's leading producers of premium glass bottles for spirits, wine, and champagne, operating furnaces in France, the UAE, and Mexico. It contributed $1.03 billion, or 49%, of FY25 group revenue. The Australasian Beverage Cans division manufactures aluminium cans from plants across Australia and New Zealand, contributing $777 million (37%). Gawler, a glass container plant in South Australia, produces standard glass bottles for the domestic wine industry, adding $285 million (14%). The company reports in Australian dollars, but roughly 60% of earnings are generated in euros through Saverglass.

Where the Growth Is

The Cans division is the structural growth engine. It currently contributes 37% of group revenue and is growing at 4-6% annually, driven by a persistent shift in Australian beverage consumption from glass to aluminium cans, particularly in beer and ready-to-drink formats. Management targets an incremental $50 million of EBIT from the division by FY30. We model 80% delivery, or roughly $40 million. First-half FY26 volumes grew 11%, off a base that itself grew 12% the prior year. This is genuine momentum, not base-effect flattery. At current rates, Cans will overtake Saverglass as the largest revenue contributor by FY28.

Competitive Position

The competitive advantages differ sharply by segment. In Cans, Orora operates one half of a duopoly with Visy. Building a new can manufacturing line costs upward of $500 million, and expansion typically requires customer-backed contracts before capital is committed. No new entrant has attempted to crack the Australian market in decades. These barriers are structural and unlikely to erode within five to seven years. Saverglass competes differently: it holds a library of over 39,000 bespoke bottle moulds, creating switching costs for spirits and wine brands whose packaging is integral to their identity. The moat here is narrower and more dependent on continuous design innovation and customer relationships. Gawler operates with minimal competitive advantage in commodity glass, serving a domestic wine market that is itself declining.

Management & Capital Discipline

Management's track record is mixed. The sale of the North American distribution business (OPS) at 9.9 times EBITDA was well-timed and crisply executed. The Saverglass acquisition at approximately 16.5 times EBIT was made near the top of the glass cycle and has yet to demonstrate value creation. A $101 million share buyback was conducted in the first half of FY26 before being paused as leverage increased. One honest observation: management affirmed Saverglass earnings guidance, then cut it within two months. That sequence warrants a structural haircut on any forward Glass earnings forecast. Capex and operational guidance, by contrast, has been consistently reliable.

Financial Position

The balance sheet is strong relative to peers. Net debt to EBITDA sits at 0.9 times against a target range of 1.5 to 2.5 times, leaving substantial headroom. Undrawn credit facilities total $942 million. No material debt matures before May 2027. Interest coverage is comfortable. For context, O-I Glass, the closest global peer, operates at 4.5 times leverage. Orora could comfortably absorb a 30-40% earnings decline without breaching covenants, providing a meaningful cushion against the Saverglass uncertainty that dominates the share price.

Read the full report

Our complete analysis of Orora Limited includes:

Financial estimates DCF valuation Fair value & scenarios Investment rating
Subscribe